Literature DB >> 18521242

Longitudinal growth following treatment for osteosarcoma.

W P Cool1, R J Grimer, S R Carter, R M Tillman, A M Davies.   

Abstract

Purpose. The purpose of this study was to analyse the height at diagnosis and growth in 72 skeletally immature children who had been treated for osteosarcoma in the area of the knee.Subjects. Of the patients, the average age at diagnosis was 10 years in girls and 12 years in boys. All children received neo-adjuvant chemotherapy, and had limb salvage by endoprosthetic replacement.Results and conclusion. The results of this study indicate that there is no evidence that children with osteosarcoma are taller at diagnosis than their normal counterparts. However, there was a marked retardation in growth in the year following the administration of cytotoxic chemotherapy. There were 19 children who reached skeletal maturity. The final height in these children was not significantly different from the normal population.

Entities:  

Year:  1998        PMID: 18521242      PMCID: PMC2395383          DOI: 10.1080/13577149878073

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  7 in total

1.  A study of bone growth in normal children and its relationship to skeletal maturation.

Authors:  G S TUPMAN
Journal:  J Bone Joint Surg Br       Date:  1962-02

2.  Stature and malignant tumors of bone in childhood and adolescence.

Authors:  J F Fraumeni
Journal:  Cancer       Date:  1967-06       Impact factor: 6.860

3.  Do growth chart centiles need a face lift?

Authors:  T J Cole
Journal:  BMJ       Date:  1994-03-05

4.  A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.

Authors:  V H Bramwell; M Burgers; R Sneath; R Souhami; A T van Oosterom; P A Voûte; J Rouesse; D Spooner; A W Craft; R Somers
Journal:  J Clin Oncol       Date:  1992-10       Impact factor: 44.544

5.  Uncemented intramedullary fixation of implants using polyethylene sleeves. A roentgenographic study.

Authors:  A E Inglis; P S Walker; R S Sneath; R Grimer; J T Scales
Journal:  Clin Orthop Relat Res       Date:  1992-11       Impact factor: 4.176

6.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

7.  The effect of chemotherapy on growth in the skeletally immature individual.

Authors:  D B Glasser; K Duane; J M Lane; J H Healey; B Caparros-Sison
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

  7 in total
  6 in total

Review 1.  Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.

Authors:  D Matthew Gianferante; Lisa Mirabello; Sharon A Savage
Journal:  Nat Rev Endocrinol       Date:  2017-03-24       Impact factor: 43.330

2.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

3.  Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries.

Authors:  Anke H Maitland-van der Zee; Bruce C Carleton; Zulfan Zazuli; Catharina J P Op 't Hoog; Susanne J H Vijverberg; Rosalinde Masereeuw; Shahrad Rod Rassekh; Mara Medeiros; Rodolfo Rivas-Ruiz
Journal:  Pediatr Nephrol       Date:  2022-06-24       Impact factor: 3.714

Review 4.  Does Systemic Chemotherapy Influence Skeletal Growth of Young Osteosarcoma Patients as a Treatment-Related Late Adverse Effect?

Authors:  Manabu Hoshi; Naoto Oebisu; Tadashi Iwai; Yoshitaka Ban; Hiroaki Nakamura
Journal:  Curr Oncol       Date:  2022-06-04       Impact factor: 3.109

5.  Using epidemiology and genomics to understand osteosarcoma etiology.

Authors:  Sharon A Savage; Lisa Mirabello
Journal:  Sarcoma       Date:  2011-03-08

6.  Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study.

Authors:  Clímaco Andres Jiménez-Triana; Osvaldo D Castelán-Martínez; Rodolfo Rivas-Ruiz; Ricardo Jiménez-Méndez; Aurora Medina; Patricia Clark; Rod Rassekh; Gilberto Castañeda-Hernández; Bruce Carleton; Mara Medeiros
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.